GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% Solution is indicated as a replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients ≥2 years.
![GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% logo.](/content/experience-fragments/takeda/gammagard/us/en/hcp/header/master/_jcr_content/root/container_1325140548/container_6852551/container/image.coreimg.svg/1755842420057/logo-gammagard-white.svg){kind=logo}
Patient Resources for GAMMAGARD LIQUID
Patient education can play an important role in chronic disease management
We know you want to be there for your patients with PI to support them throughout their treatment journey. That’s why we’ve put together resources to help equip your patients and their loved ones with the information they may need to lead a healthy life while living with PI.
MyIgSource
This is an online resource that offers information and support for patients, at diagnosis and throughout their PI journey. It is open to all PI patients and their caregivers regardless of which treatment they are on.
Your patients can visit MyIgSource.com or call 1-855-250-5111 to:
- Learn more about living with and managing their condition
- Sign up to receive educational materials about PI
- Connect via phone or online with patient advocates who have PI or who have loved ones with PI
- Register for events focusing on PI disease education topics
Organizations for your patients
Your patients may benefit from connecting with these foundations and professional societies that focus on a multitude of different things regarding PI.
Immune Deficiency Foundation (IDF)*
The IDF site provides timely information and valuable resources for patients and families living with PI by:
- Helping patients gain a broader understanding of PI through education and outreach efforts
- Promoting, participating in, and conducting research about PI and its treatment options
- Addressing patient needs through programs that focus on issues such as insurance reimbursement, ensuring the safety and availability of immunoglobulin therapy, and maintaining and enhancing patient access to treatment options
Jeffrey Modell Foundation (JMF)*
The JMF is a public charity that offers a Primary Immunodeficiency Resource Center online.
*This organization is a third-party resource and not associated with Takeda.
Stay ahead with insights that empower your patient care
Sign up for information regarding GAMMAGARD LIQUID.